Biểu đồ giá cổ phiếu ATXI
ATXI Cổ tức
Avenue Therapeutics Inc
$0.32
20.57%
$0.05
Khi đóng cửa: Jun 18, 16:00:00 GMT-4
$0.32
0%
$0
Phiên sau giờ: Jun 18, 20:00:00 GMT-4
Quay lại
Avenue Therapeutics Inc (ATXI) Cổ tức
Thống kê chính
Giá đóng cửa trước
$0.27
Giá mở cửa
$0.27
Phạm vi ngày
$0.27 - $0.3255
Phạm vi 52 tuần
$0.15 - $0.9699
Khối lượng
1
Khối lượng trung bình
5.2K
Tỷ suất cổ tức
--
EPS (TTM)
-0.96
Vốn hóa thị trường
$1.0M
ATXI là gì?
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. The company is headquartered in Bay Harbor Islands, Florida and currently employs 1 full-time employees. The company went IPO on 2017-06-27. The firm is focused on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidate, intravenous tramadol (IV tramadol) is a novel therapy in development in the United States for managing post-operative pain as an alternative to conventional narcotics. The drug is designed to use a dual mechanism of action to block a patient’s pain signal with reduced abuse potential. This unique mechanism of action includes an opioid agonist and an inhibitor of norepinephrine and serotonin re-uptake.
